Bacteriophage immunotherapy with artificial antigen-directed immune labeling against bacterial infection
Science Advances · 2025
DOI: 10.1126/sciadv.adr1911 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Minjun Yao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Bacterial Infections, Bacteriophages, Immunotherapy, Phage Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Bacteriophage therapy has been recognized as a promising anti-infection alternative, while its clinical therapeutic outcomes are compromised due to the development of bacterial resistance, ongoing host immune dysfunction at infection sites, and their failure to adequately revitalize host immunity. Here, we present a strategy for artificial antigen-directed immune labeling of bacteria, capitalizing on residual bacteriophage capsids on bacterial surfaces, which enable immune cells to achieve quicker bacterial recognition and clearance. Specifically, Mn 2+ @Man-phage anchored on bacterial surfaces and provided artificial recognition sites that enabled macrophages to phagocytize via mannose receptors, accompanied by enhanced bactericidal activity triggered by manganese ions in response to an infectious microenvironment. Moreover, immune labeling–activated macrophages enhanced antigen presentation at infection sites, further boosting specific T cell–mediated adaptive immune responses and infection eradication effects. Overall, this study illustrates a scalable bacteriophage immune therapy based on precise biological labeling and targeted modulation of immune responses, bridging the natural divide between bacteriophages and host immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang, China.
- Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou, Zhejiang, China.
- Clinical Research Center of Motor System Disease of Zhejiang Province, Hangzhou, Zhejiang, China.
- Alberta Institute, Wenzhou Medical University, Wenzhou, Zhejiang, China.
ORCID-Profile: Minjun Yao, Liang Chen, Zhenxuan Shao, Yucheng Xue, Hao Zhou, Shenzhi Zhao, Haochen Mou, Shixin Chen, Eloy Yinwang, Jiahao Zhang, Xiaoyong Wu, Kanbin Wang, Xunzi Cai, Chen Zhuang, Rongxin He, Jianbin Xu, Zhaoming Ye
Zitieren
APA
Yao, M., Chen, L., Jin, X., Shao, Z., Xue, Y., Zhang, W., Zhou, H., Zhao, S., Mou, H., Chen, S., Yinwang, E., Zhang, J., Wu, X., Wang, K., Zhou, C., Cai, X., Zhuang, C., He, R., Xu, J., & Ye, Z. (2025). Bacteriophage immunotherapy with artificial antigen-directed immune labeling against bacterial infection. Science Advances. https://doi.org/10.1126/sciadv.adr1911
Vancouver
Yao M, Chen L, Jin X, Shao Z, Xue Y, Zhang W, et al. Bacteriophage immunotherapy with artificial antigen-directed immune labeling against bacterial infection. Science Advances. 2025. doi:10.1126/sciadv.adr1911
BibTeX
@article{Yao2025,
author = {Yao, Minjun and Chen, Liang and Jin, Xiaoqiang and Shao, Zhenxuan and Xue, Yucheng and Zhang, Wenkan and Zhou, Hao and Zhao, Shenzhi and Mou, Haochen and Chen, Shixin and Yinwang, Eloy and Zhang, Jiahao and Wu, Xiaoyong and Wang, Kanbin and Zhou, Chenhe and Cai, Xunzi and Zhuang, Chen and He, Rongxin and Xu, Jianbin and Ye, Zhaoming},
title = {Bacteriophage immunotherapy with artificial antigen-directed immune labeling against bacterial infection},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adr1911}
}
EUVIMED